How socialist price controls will harm American patients
The Trump administration is planning to propose one of the biggest changes to Medicare in decades. The draft rule aims to reduce government spending by linking Medicare drug reimbursement rates… Read More
Matt Schlapp: ‘Medicare-for-all’ is a $32 trillion utopian taxpayer-funded fantasy. Don’t be fooled, America
Wednesday in Congress, the Democrat Chairman of the House Ways and Means Committee is holding a hearing titled “Pathways to Universal Healthcare Coverage.” Democrats on the Committee will no doubt… Read More
CAGW Joins Coalition to Fight Against Socialized Medicine
Today, conservative organizations announced and launched the “Coalition Against Socialized Medicine” that will address and educate the public on why adopting a “Medicare for All” plan would destroy… Read More
On High Drug Prices, Republicans Shouldn’t Take the Arbitration Bait
With bipartisan consensus that drug prices are too high, the search is on for so-called “middle-of-the-road” policies that have a shot at becoming law. Thus far, this has only resulted… Read More
Medicare proposal threatens cures
House Speaker Nancy Pelosi is considering a monumental change to Medicare — and believes that President Donald Trump might support her plan. Her big idea? Binding arbitration — a… Read More
Sally Pipes: ‘Medicare-for-all’ is worse than the CBO says it is (much worse)
This week, the House Budget Committee hosted three representatives from the Congressional Budget Office to discuss their new report analyzing the prospects for a single-payer health care system in America. Read More
Evan Lubline: Policy change would harm state’s Medicare beneficiaries
In the United States, an estimated 43 million family members—including spouses, children and siblings—are serving as home caregivers for people 50 and older. Medicare is a key support for millions… Read More
The new Right: Who needs innovation when you can stifle it?
The populism that is coursing through the veins of Republicans in Congress right now is frightening. It is like the Hulk breaking out of Dr. Banner: It is unstoppable and… Read More
Binding arbitration policy would cause drug development pipeline to run dry
Pharmaceutical giant Biogen recently pulled the plug on its experimental Alzheimer’s drug after disappointing clinical trial results. Read More
U.S. Should Not Import Foreign Price Controls on Drugs
On May 20, 2019, Health and Human Services (HHS) Secretary Alex Azar, spoke before the 72nd World Health Assembly, the decision-making body of the World Health Organization (WHO) under the… Read More